The scientists of the Central Drug Research Institute of India (CDRI), Lucknow, conducted clinical tests on Memory Plus, a drug which owes its origin to the traditional herb 'Brahmi'. The tests established its efficacy in children suffering from attention deficit hyperactivity disorder (ADHD), a condition in which children are hyperactive and lack the will or the power to concentrate. Trials were conducted in the department of paediatrics, BRD Medical College, Gorakhpur by administering Memory Plus and placebos (inert substances) on children in the age group of 8-10 years for a period of 12 months.
O
P
E
N
How come Andhra is left out of the mining loot story ? It is good for the nation if we learn to keep environmental and...
The UN environment report states that Ganga would disappear by 2030.There would be no need to train engineers or even Ganga...
A report published in the Journal of the Federation of American Societies for Experimental Biology suggests that babies of...